Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase Mu 4 (GSTM4) is a cytosolic enzyme of the mu class, encoded by the GSTM4 gene located on chromosome 1p13.3[1][3][8]. It catalyzes the conjugation of reduced glutathione to a diverse array of endogenous and exogenous electrophilic compounds, including drugs, carcinogens, and products of oxidative stress, facilitating their detoxification[1][3][4][5]. GSTM4 plays important roles in cellular protection, drug metabolism, and regulation of inflammatory mediators such as leukotriene C4, which may influence susceptibility and outcomes in diseases like cancer and inflammation[1][3][4][5][8]. Its gene displays polymorphism, leading to individual differences in toxin and drug metabolism. GSTM4 interacts with multiple drugs and is implicated in chemoresistance and differential drug responses[1][3][5].
Conjugates reduced glutathione to hydrophobic electrophiles, facilitating their excretion and detoxification[1][3][4][5]\nInhibition of GSTM4 reduces detoxification and may sensitize cancer cells to chemotherapeutics[5]
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase Mu 4 (GSTM4).